Cyclopamine

For research use only.

Catalog No.S1146 Synonyms: 11-deoxojervine

102 publications

Cyclopamine Chemical Structure

CAS No. 4449-51-8

Cyclopamine (11-deoxojervine) is a specific Hedgehog (Hh) signaling pathway antagonist of Smoothened (Smo) with IC50 of 46 nM in TM3Hh12 cells.

Selleck's Cyclopamine has been cited by 102 publications

Purity & Quality Control

Choose Selective Hedgehog/Smoothened Inhibitors

Biological Activity

Description Cyclopamine (11-deoxojervine) is a specific Hedgehog (Hh) signaling pathway antagonist of Smoothened (Smo) with IC50 of 46 nM in TM3Hh12 cells.
Targets
Smoothened [1]
(TM3Hh12 cells)
46 nM
In vitro

Cyclopamine inhibits the Hedgehog signaling pathway with an IC50 of 46 nM, and blocks the activity of human Smo receptor expressed in CHO-K1 cells in [3H]Hh-Ag binding assay with an IC50 of 280 nM. [1] Cyclopamine significantly inhibits Hedgehog pathway activity in a dose-dependent manner in gut-derived tumor cell lines expressing Patched (PTCH) mRNA, and induces growth inhibition of those tumor cell lines by 75-95% at the concentration of 3 μM, but ineffective towards the colon tumor cells without PTCH mRNA expression, suggesting the effects of Cyclopamine treatment are Hedgehog pathway related rather than generally cytotoxic. [2] By blocking Hedgehog signaling through direct interaction with Smo, Cyclopamine (10 μM) inhibits the proliferation of SMOhigh Cyclopamine-responsive cell lines L3.6sl and Panc 05.04 by 75-80%, and increases the apoptosis by 2.5- to 3.5-fold, without affecting the BxPC3-SMOlow cell line. [3] Cyclopamine treatment significantly decreases of Snail mRNA and increasea E-cadherin transcripts in the E3LZ10.7 cell line. Independent of inhibition of cell growth, Cyclopamine treatment significantly inhibits the invasive phenotype of Hedgehog-dependent L3.6pl cells, causing a >500-fold reduction in the number of transmigrating cells, but not that of the Hedgehog-independent cell line Panc-1. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
OS-RC-2 NWrKSIhUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF\4W3NKSzVyPUWuPFY3PiEQvF2= NUnGXHNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
DOHH-2 Mn3PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnJR|UxRTlwM{W2PFkh|ryP NHHwR|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
no-10 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTlwOUCzPUDPxE1? MkP3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LS-513 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\VUGlEPTB;MUGuN|U1PyEQvF2= MmXGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
ALL-PO MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;CcWVKSzVyPUGxMlc4OzRizszN NGLzW289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
8-MG-BA M4HLWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDHe2pKSzVyPUGzMlEyOjNizszN NUf2Wpc4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
RPMI-8402 M1:yRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3HKZ2lEPTB;MUWuPFU{PyEQvF2= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
EoL-1-cell NE\lPYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIPVOZpKSzVyPUG4MlU6PDhizszN MkjCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
NALM-6 M1rYbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnL3TWM2OD1zOT6wNVY4KM7:TR?= NInNZ249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
DEL NI\IXlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUK4SHp[UUN3ME2yNE4yPDdzIN88US=> MnrXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
SR NUG3bY5RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWq0dFJuUUN3ME2yN{43PzF3IN88US=> NGfvWVE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
697 M4HOUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlO3TWM2OD1{Nj62NVU2KM7:TR?= Mki2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
COLO-829 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYrOfXljUUN3ME2yOk45PDh|IN88US=> NWTDbGhVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
EVSA-T MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2fBe2lEPTB;MkeuOVU3OSEQvF2= NIDLe2c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
ATN-1 M3m2Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYfoVIhDUUN3ME2zNU4zOzJ7IN88US=> M3Xr[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
L-363 MnfGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HYfWlEPTB;M{GuO|Q3OSEQvF2= M1jzWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
LAMA-84 NH[y[5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYG4clA{UUN3ME2zNk42OjFzIN88US=> NXmzNVZTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
NOS-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2DMUWlEPTB;M{SuNlk2PiEQvF2= MoSwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
BB30-HNC MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn\nTWM2OD1|ND6zN|A3KM7:TR?= MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
BC-1 M3rOPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXTJbo1ZUUN3ME2zO{46PzR4IN88US=> MmXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
IST-SL2 M4CzcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fi[mlEPTB;M{iuNlI1KM7:TR?= MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
D-392MG NWLMSpBsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTRyLkKyNVUh|ryP NEe1Xlg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
no-11 NVfmR4hNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFzMcFBKSzVyPUSwMlU2OjFizszN MkT3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LC4-1 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7jZ5VKSzVyPUSwMlg4OTZizszN MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
A388 MlPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2HDVGlEPTB;NEKuOVg1QCEQvF2= M4TkXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
NTERA-S-cl-D1 NE\BSpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXK1ZpBRUUN3ME20Nk44ODd2IN88US=> MmmyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
CESS MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTR2LkKyN|Ih|ryP MmDaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
RS4-11 MnrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzVTWM2OD12OT6wPVM5KM7:TR?= M1m2S|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
MS-1 M4G2PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnroTWM2OD13MD65N|UyKM7:TR?= MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
CTV-1 NGO1WmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFPjR2hKSzVyPUWxMlA4PCEQvF2= M1LXPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
D-502MG MmrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn;kTWM2OD13MT62NlcyKM7:TR?= MlznQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
ML-2 MkfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{TZO2lEPTB;NUKuPVE6PSEQvF2= Mn7GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
SK-NEP-1 NETuSlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TvXWlEPTB;NUOuN|kzOyEQvF2= M1XoN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
LOXIMVI NFfVcoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4nRW2lEPTB;NUOuOVg5PCEQvF2= MnjJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
DJM-1 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWHaSmROUUN3ME21Ok4{OzlzIN88US=> NF;vdFY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
GI-1 MkXmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3m1T2lEPTB;NU[uOlE1QSEQvF2= NVfNbIJWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
IST-MES1 Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXqxeVkzUUN3ME22NE42PDl|IN88US=> NYDDeXpsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
MV-4-11 M2LNSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVqx[HplUUN3ME22NE43PTN6IN88US=> Mn20QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
OVCAR-4 NHXQeoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTZ|LkW2OVch|ryP NEjYTVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
KE-37 NYLQNFVDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTzTWM2OD14Nj6yOlY5KM7:TR?= M3fM[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
D-542MG NXnSUm1qT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVTJR|UxRTZ6LkSxN|Uh|ryP MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
MHH-PREB-1 M4nYcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWXhfHRxUUN3ME23Nk45PDRzIN88US=> NVHqdoRzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
MRK-nu-1 Mn7kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWizfpRFUUN3ME23N{41PzB3IN88US=> NFPrO3M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
D-247MG MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HEdGlEPTB;N{OuOVQ1OiEQvF2= MmHyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
OCI-AML2 NUfMeYlyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnHrTWM2OD15Nj65N|Y6KM7:TR?= NVfUNWNiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
LP-1 NWnjXWp6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInHdVhKSzVyPUiyMlg4OzFizszN MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
HCC1599 NVfsS4poT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV;JR|UxRTh2LkK4N|ch|ryP MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KARPAS-45 NX3CSlRET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7wN|VWUUN3ME24OE43QTl{IN88US=> NFPvdmw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
BE-13 M2npZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYLJR|UxRTl7LkC0O|ch|ryP M{jMUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
GCIY MnzXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmXMTWM2OD17OT6wPVU1KM7:TR?= NFLKNHk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
BV-173 MkPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHy4Wm1KSzVyPUGwNE4{OjVizszN Mk\4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LB2518-MEL MnnaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnTUTWM2OD1zMECuO|g6KM7:TR?= Mke5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
KS-1 MojZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4W1fmlEPTB;MUCxMlY{QSEQvF2= MoHSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
MOLT-16 Mk\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPZenA1UUN3ME2xNFQvQTh4IN88US=> NIXmW|I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
NCI-H1770 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPuTWM2OD1zMEiuO|g1KM7:TR?= NGriUng9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
NCI-H82 NILWSVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\Qbo1KSzVyPUGxNE46PzZizszN NFO5ZYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
NCCIT MoD2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWmyVXI3UUN3ME2xNVIvPTJ7IN88US=> MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KALS-1 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHITpBuUUN3ME2xNVUvQTRzIN88US=> M1LWUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
LB2241-RCC NWTz[HdsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlHsTWM2OD1zMU[uOlc6KM7:TR?= M3XoOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
HH NHfpcGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\6TWM2OD1zMUeuN|k2KM7:TR?= MnjrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
HD-MY-Z MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEfBeVBKSzVyPUGxPE41QDhizszN NViwRnJ7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
EB-3 M1KwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{TSXGlEPTB;MUKzMlA6PCEQvF2= MnnFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
BL-70 M2HTT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHP[ZRKSzVyPUGyN{4yOjdizszN MnOzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
K-562 M4ryb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvpOpNKSzVyPUGyOk4zPDVizszN M2LiNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
HT-144 NVPqN5Q{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3LqfGlEPTB;MUOzMlE3PCEQvF2= MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
PF-382 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{fVeWlEPTB;MUO0MlM3OSEQvF2= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
RPMI-8226 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTF|NT6wOFUh|ryP NUHzT|hURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
NCI-H1355 MmrqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTF|NT61PFch|ryP NF60S5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
LXF-289 M1TIdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmHITWM2OD1zM{muO|gyKM7:TR?= M2TwZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
NCI-H69 MmT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1fsWmlEPTB;MUSyMlk{OiEQvF2= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
SK-MEL-1 Mn61S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnjpTWM2OD1zNEeuNVMh|ryP MkDIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
KARPAS-299 NIHMT4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVjJR|UxRTF2OT6xNkDPxE1? NXXMWJBqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
GB-1 MoCxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPqeXMzUUN3ME2xOFkvOzJ{IN88US=> NXv0ZmF5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
CMK M3XrPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnhfJFKSzVyPUG0PU42OTVizszN MkCzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
MPP-89 M2jjPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{D5eWlEPTB;MUW2MlA{PSEQvF2= NUj5[5JURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
KU812 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXu1ZmhtUUN3ME2xOlEvQTB{IN88US=> M3XGdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
REH M2S0[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnYTWM2OD1zNkKuNVI2KM7:TR?= MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
NEC8 NXP3TJNZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYXpZlJFUUN3ME2xOlUvODJ4IN88US=> MmXYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
KP-N-YS MkH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmLqTWM2OD1zNkiuN|k2KM7:TR?= NHq1SXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
Ramos-2G6-4C10 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn62TWM2OD1zNkmuPVE2KM7:TR?= MmeyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
Becker NXPpdIp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF3rbIpKSzVyPUG3OE4yQCEQvF2= NIjkVmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
LB647-SCLC MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1:0d2lEPTB;MUe1Mlg1PSEQvF2= MkTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LU-139 M3\JSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfFbJJKSzVyPUG3PE4xOTlizszN MmLlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
QIMR-WIL M2LIT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fEU2lEPTB;MUe5MlY1PiEQvF2= M{nMNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
NCI-H1395 M1r6S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYLJR|UxRTF5OT65PVYh|ryP NXq5Nmt5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
NOMO-1 NYPmZoJHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTF6Mj64OUDPxE1? MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
GI-ME-N M{\FU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfSOo9KSzVyPUG4O{46PjlizszN MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KMS-12-PE MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlrJTWM2OD1zOEmuNlc{KM7:TR?= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
Daudi MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHVcnZKSzVyPUG5NU4yOjhizszN M1\XS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
LB996-RCC MoHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnHVTWM2OD1zOUGuOlk6KM7:TR?= MlvyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
NCI-H2107 NU\qTVFuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXLaOpJZUUN3ME2xPVMvPzN7IN88US=> M1exO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
SK-PN-DW NGHtXHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2L5dGlEPTB;MUm0MlcyQSEQvF2= NXTLRlVKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
MC-CAR MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHI[ZlHUUN3ME2yNFIvOjV|IN88US=> M2XU[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
SNB75 M4LSWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NES1OItKSzVyPUKyNU46PCEQvF2= NXfBdW1JRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
ES4 M2DIOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVLJR|UxRTJ{Mz63PFMh|ryP M4e2dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
KARPAS-422 M13sfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3fnPWlEPTB;MkK4MlM2OiEQvF2= NXHHUmYxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
NCI-H1648 NU\UT2hnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MY\JR|UxRTJ{OT60PFkh|ryP MnP6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
ES6 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1K3N2lEPTB;MkO5MlQ{KM7:TR?= NVuwZpA4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
KNS-81-FD NHi1VWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NInkVoxKSzVyPUK0NU4yQTdizszN M1:5[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
JAR MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXZd2FKSzVyPUK1Ok4zOjVizszN MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
NB1 MoTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV;mVVZ3UUN3ME2yOlAvPTF4IN88US=> NUXtV21uRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
D-336MG M3nubGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlXCTWM2OD1{NkCuOlk5KM7:TR?= Mn34QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
BC-3 NIrzPVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M37JTWlEPTB;Mk[1MlE4QCEQvF2= Mn\nQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
HCC2218 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF30XoJKSzVyPUK2Ok41OTVizszN NFnGTW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
TE-9 MmHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnHWTWM2OD1{Nk[uOlI4KM7:TR?= M37xSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
LB1047-RCC MlyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYPJR|UxRTJ4Nj63OVMh|ryP NX3HRWltRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
CTB-1 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NImzdI5KSzVyPUK2PU46PzNizszN M{\DbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
NB7 NF\KR4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVO2O2hSUUN3ME2yO|Eh|ryP NWLVUnVwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
ST486 NXrj[4pzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2HuZWlEPTB;Mke3MlQyOiEQvF2= NYrOT2s6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
HCC1187 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHDTWM2OD1{OEKuPFEyKM7:TR?= NWXYWnJjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
NCI-SNU-16 NIjaVIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NED0epZKSzVyPUK4OE4zPDhizszN Mk\GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
COR-L279 NXq5enllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV33PXdVUUN3ME2yPVEvPTh2IN88US=> NV;pfZl{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
ES8 NYPYTJI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;pTWM2OD1{OUSuNVgzKM7:TR?= Moi2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
U-698-M MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHkRYxuUUN3ME2yPVgvOjR|IN88US=> NXzPO45iRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
HEL Ml\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTNyOT6xOFkh|ryP MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KINGS-1 NX21UG9PT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml\lTWM2OD1|MUCuOlc1KM7:TR?= MlrnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
KY821 NEf3T41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkLITWM2OD1|M{[uOVk2KM7:TR?= M170XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
MZ1-PC NWTo[pZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHPclRKSzVyPUO0OU43OThizszN MonIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LS-411N NE[xUm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7pTWM2OD1|NUSuOlYh|ryP M3PycFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
SIG-M5 NWXCNVJRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3zoVWlEPTB;M{W5Mlc5OiEQvF2= M2HXTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
HT MonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1;WV2lEPTB;M{[3MlcyOSEQvF2= NYnJbnNvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
HC-1 NXu0ZppvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGntZpdKSzVyPUO2O{44QDdizszN Ml3hQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
NCI-H1694 M1HGN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRTN5Mj65N|Qh|ryP NEP4V4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
BB65-RCC MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzvTWM2OD1|N{[uNlQ2KM7:TR?= MojWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
HAL-01 M1\wOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn\tTWM2OD1|N{muPFM5KM7:TR?= M1TrUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
ARH-77 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\SelVVUUN3ME2zPVQvODB6IN88US=> NEXk[Ic9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
MZ7-mel NHrwTpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mmq4TWM2OD1|OUeuNlM{KM7:TR?= NYXNNlVmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
SIMA MmHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnhRYx6UUN3ME20NFMvQTN|IN88US=> NFrFRoc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
DG-75 NUflc41wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVTJR|UxRTRzNT62PVgh|ryP MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
HUTU-80 Mm\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnPSTWM2OD12MUmuNVg2KM7:TR?= NIL4V4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
KNS-42 M2\GcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXwTWM2OD12MkWuPFE2KM7:TR?= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
SH-4 NULGeHVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\UNXNKSzVyPUSyO{42PjVizszN M2TjRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
L-540 M{DxNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;rNY1EUUN3ME20N|EvODNzIN88US=> M{T3SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
NB10 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXPWWpg4UUN3ME20OFEvOjN2IN88US=> NFrER4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
ES1 NYrQ[3hKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWjJR|UxRTR3Mj63OVMh|ryP MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KMOE-2 MlfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\1S2lEPTB;NEW2MlcyOSEQvF2= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
MC116 MnTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2S1cGlEPTB;NEW4MlEyPiEQvF2= NWH6TnNWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjV2MUK5M{c,W0GQR1XSQE9iRg>?
RCC10RGB MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH\JTXhKSzVyPUS2NE4xODVizszN M{TLfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
RL95-2 M2DPNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWfJR|UxRTR4MD6yN|ch|ryP MkX3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
Raji NVnBOY0xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzZTWM2OD12NkiuNVQ{KM7:TR?= M3TaTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
CAS-1 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFvyZXRKSzVyPUS3Nk4xPzNizszN NIixOIE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
Calu-6 M2r5Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjseFJKSzVyPUS3OU4zPjVizszN MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyOVQyOjlxJ{7TRW5ITVJ:L3G+
KG-1 NYHMXnRkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1XsOmlEPTB;NEe4MlQ1KM7:TR?= MmrxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlU1OTJ7Lze+V2FPT0WUPD;hQi=>
LB771-HNC MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTR6Mj6yN|Ih|ryP M1u5XlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI2PDF{OT:nQnNCVkeHUkyvZV4>
ACN MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTR7Mz61PVkh|ryP NGDYO2c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
KM12 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfCcWhNUUN3ME20PVYvPTh7IN88US=> NFKyfJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzPTRzMkmvK|5USU6JRWK8M4E,
U2OS NEH2S|FHfW6ldHnvckBie3OjeR?= NW\ob|V1SmmwZHnu[{Bi\m[rbnn0fUB1dyC5aXzkJJR6eGViU33vJIV5eHKnc4Pl[EBqdiCXMl;TJINmdGy|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFvkJF0hOC5yMUK0JO69VS5? Mn3zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyNkO1NlIoRjJ|ME[zOVIzRC:jPh?=
U2OS MY\GeY5kfGmxbjDhd5NigQ>? MW[yJIhzew>? MWnEbZNxdGGlZX3lcpQhd2ZiW{PIYYN6[2yxcHHtbY5mKG[{b32ge4lt\CC2eYDlJHNudyCneIDy[ZN{\WRiaX6gWVJQWyClZXzsd{Bi\nSncjCyJIhzeyCkeTDzZ4lvfGmubHH0bY9vKGOxdX70bY5oNCCNaTC9JFAvODF{NzFOwG0v NGe3bGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C2N|UzOid-MkOwOlM2OjJ:L3G+
TM3 NXHVeo5zTnWwY4Tpc44h[XO|YYm= MXS0PEBpenN? MUHJcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKFSPMzDj[YxteyCkZXHybY5oKHCWQT24fGdtcS2OdXOgdoVxd3K2ZYKgZ49ve3S{dXP0JIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBud2S3bHH0bY9vKG:oIFfsbUBi\nSncjC0PEBpenNiYomgcJVkcW[ncnHz[UBie3OjeTygTWM2OCB;IECuNFQ3KM7:TT6= MmHuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlyOUG1OVkoRjF7MEmxOVU6RC:jPh?=
HCC827 NYKyeFBITnWwY4Tpc44h[XO|YYm= MkLRSIl{eGyjY3Xt[Y51KG:oIGuzTH0u[3mlbH;wZY1qdmViZoLvcUBUVU9iVkSwOG0hdXW2YX70JIlvKGenZnn0bY5q[iC{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFvpJF0hOC5yNUGg{txONg>? NFXpS3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEe4O|E2Pid-Mki3PFcyPTZ:L3G+
HEK293 NYHhfI5VTnWwY4Tpc44h[XO|YYm= MUKyJIhzew>? MW\EbZNxdGGlZX3lcpQhd2ZiQl;ETXB[NWyjYnXscIVlKGO7Y3zvdIFucW6nIH\yc40hcHWvYX6gV41wKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[W[2ZYKgNkBpenNiYomg[ox2d3Knc3PlcoNmKG2rY4Lvd4NweHluIFnDOVAhRSByLkC2OEDPxE1w NFe3PYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK2PFU2OSd-MkKyOlg2PTF:L3G+
Shh Light2 Mm\KSpVv[3Srb36gZZN{[Xl? M{LQVVMxKGi{cx?= M2XieGlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gcY92e2ViU3joJGxq\2i2MjDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHOxbnnjJIhm\GenaH;nMYlv\HWlZXSgS2xKOS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhdWWjc4Xy[YQh[W[2ZYKgN|AhcHK|IHL5JIR2[WxibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyIE2gNE4xPzRzIN88UU4> MmHDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd3NkezO|EoRjJ5NU[3N|cyRC:jPh?=
U2OS M1\xZmZ2dmO2aX;uJIF{e2G7 MVjCbY5lcW6pIHHm[olvcXS7IITvJHNudyCGNEezTEBufXSjboSg[ZhxemW|c3XkJIlvKFV{T2OgZ4VtdHNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiS3SgQUAxNjFzNjFOwG0v M1fKNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|ME[zOVIzLz5{M{C2N|UzOjxxYU6=
DaOY NYfETmxNTnWwY4Tpc44h[XO|YYm= NFfWd4I1QCCqcoO= NYDGOohMUW6qaXLpeIlwdiCxZjDI[YRo\WixZzDzbYdv[WyrbnegbY4hcHWvYX6gSIFQYSClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCJbHmxJI1TVkFiZYjwdoV{e2mxbjDh[pRmeiB2ODDodpMh[nliUmStVGNTKGGwYXz5d4l{NCCLQ{WwJF0hOC5zNjFOwG0v NF;BcZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFcyPid-MkS5NFA4OTZ:L3G+
U2OS MWXGeY5kfGmxbjDhd5NigQ>? M1nvZVIhcHK| NF3Z[YxFcXOybHHj[Y1mdnRib3[gX|NJZWO7Y3zvdIFucW6nIH\yc40hW22xIFS0O|NJKG23dHHueEBmgHC{ZYPz[YQhcW5iVULPV{Bk\WyuczDh[pRmeiB{IHjyd{BjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBMcSB;IECuNlMzKM7:TT6= M1nhZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|ME[zOVIzLz5{M{C2N|UzOjxxYU6=
CHO M4izXmZ2dmO2aX;uJIF{e2G7 MVHBcpRi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHNudyC{ZXPldJRweiCneIDy[ZN{\WRiaX6gR2hQKGOnbHzzJIJ6KFt|SG3IbE1C\yCkaX7kbY5oKGG|c3H5MEBKSzVyIE2gNE4zQCEQvF2u MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTB7MUW1PUc,OTlyOUG1OVk9N2F-
Shh Light2 MkTHSpVv[3Srb36gZZN{[Xl? M3jheVQxKGi{cx?= MV\Jcohq[mm2aX;uJI9nKFOKSDDwZZRpf2G7IHnuJI1wfXOnIGPobEBNcWeqdEKgZ4VtdHNiYX\0[ZIhPDBiaILzJIJ6KEeuaT3k[ZBmdmSnboSgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCLQ{WwJF0hOC5|IN88UU4> NF3p[pI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUW5Nlc5QCd-MkG1PVI4QDh:L3G+
Shh-light2 M2\YS2Z2dmO2aX;uJIF{e2G7 MVrJcohq[mm2aX;uJI9nKFOvbz3t[YRq[XSnZDDIbEB{cWewYXzpcochcW5iaIXtZY4hW2iqLXzp[4h1OiClZXzsd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGlEPTBiPTCwMlMh|ryPLh?= Ml:wQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{Nki1OVEoRjJ{Mk[4OVUyRC:jPh?=
M210B4 MXjGeY5kfGmxbjDhd5NigQ>? NVXMRZI1OjRiaILz MV3Jcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCrbjDtc5V{\SCPMkGwRlQh[2WubIOgZZN{\XO|ZXSgZZMh\G:5boLl[5Vt[XSrb36gc4YhWHSlaDDtVm5CKGW6cILld5Nqd25iYX\0[ZIhOjRiaILzJIJ6KFKWLWDDVkBidmGueYPpd{whUUN3MDC9JFAvPDNizszNMi=> MnPzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MEC3NVYoRjJ2OUCwO|E3RC:jPh?=
Shh-Light 2 NGm3U3VHfW6ldHnvckBie3OjeR?= MlvtNkBl[Xm| MV\BcpRi\2:waYP0JIFkfGm4aYT5JIF1KFOvbzDpckBud3W|ZTDTbIguVGmpaISgNkBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIGPobE1qdmS3Y3XkJGdtcTFvcnXwc5J1\XJiYXP0bZZqfHliYX\0[ZIhOiCmYYnzJIJ6KGS3YXytcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIH3leIhw\CxiSVO1NEA:KDBwNEi0JO69VS5? MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzB4M{WyNkc,OjNyNkO1NlI9N2F-
Shh Light2 NVnFcFFQTnWwY4Tpc44h[XO|YYm= NWnJSIs1UW6qaXLpeIlwdiCxZjDTTGghcW5ibX;1d4UhW2iqIFzp[4h1OiClZXzsd{BjgSCJTFmtdoV{eG:wc3n2[UBncXKnZnz5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NEA:KDBwNTFOwG0v M17yclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7M{C5NFgxLz5zOUOwPVA5ODxxYU6=
C3H10T1/2 NUXaVZpiTnWwY4Tpc44h[XO|YYm= NH\WcmtKdmirYnn0bY9vKG:oIF6teIVzdWmwYXygV2hJKGGldHn2ZZRm\CCyYYToe4F6KGmwIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCVQVetbY5lfWOnZDDj[YxtKGSrZn\ldoVvfGmjdHnvckBjgSCjbHvhcIlv\SCyaH;zdIhifGG|ZTDhd5NigSxiSVO1NEA:KDBwNjFOwG0v MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTV7Mke4PEc,OjF3OUK3PFg9N2F-
C3H10T1/2 NITQeYhHfW6ldHnvckBie3OjeR?= NHnReWw3KGi{cx?= NXvLeI5OUW6qaXLpeIlwdiCxZjDTRWcucW6mdXPl[EBlcW[oZYLlcpRq[XSrb36gc4YhdW:3c3WgcYV{\W6laIntZYwheGy3cnnwc5RmdnRiQ{PINVBVOS9{IHPlcIx{KHSxIHHsb4FtcW6nIIDoc5NxcGG2YYPlJJBwe2m2aY\lJI9me2WxYnzhd5R{KGGodHXyJFYhcHK|LDDJR|UxKD1iMD62NkDPxE1w M4G2RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mk[4OVUyLz5{MkK2PFU2OTxxYU6=
ASZ001 MYHGeY5kfGmxbjDhd5NigQ>? NG\QV281QCCqcoO= NUS5[YdGUW6qaXLpeIlwdiCxZjDI[YRo\WixZzDzbYdv[WyrbnegbY4hdW:3c3WgRXNbODBzIHPlcIx{KGG|c3Xzd4VlKGG|IHTve45z\We3bHH0bY9vKG:oIFfsbVEhdVKQQTDlfJBz\XO|aX;uJIFnfGW{IES4JIhzeyCkeTDSWE1RS1JiYX7hcJl{cXNuIFnDOVAhRSByLk[2JO69VS5? MnW3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MEC3NVYoRjJ2OUCwO|E3RC:jPh?=
M210B4 NHftb21HfW6ldHnvckBie3OjeR?= MkL3NlQhcHK| M3H6N2lvcGmkaYTpc44hd2ZiSHXk[4Vpd2dic3nncoFtcW6pIHnuJI1wfXOnIF2yNVBDPCClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCJbHmxJI1TVkFiZYjwdoV{e2mxbjDh[pRmeiB{NDDodpMh[nliUmStVGNTKGGwYXz5d4l{NCCLQ{WwJF0hOC56IN88UU4> NX;kOGZsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA4OTZpPkK0PVAxPzF4PD;hQi=>
medulloblastoma cells M3LufGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NVfhNI1SSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDt[YR2dGyxYnzhd5RwdWFiY3XscJMhcGG{Yn;ybY5oKGindHXyc5p6\2:3czDweINpOSCpZX7lJIJ6KE2WVDDhd5NigSxiRVO1NEA:KDFizszNMi=> M3vQXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NEG3OlMyLz5zN{SxO|Y{OTxxYU6=
CHO M33pTGZ2dmO2aX;uJIF{e2G7 MV\BcpRi\2:waYP0JIFkfGm4aYT5JIF1KG2xdYPlJHNudyC{ZXPldJRweiCneIDy[ZN{\WRiaX6gR2hQKGOnbHzzJIJ6KFt|SG3IbE1C\yCkaX7kbY5oKGG|c3H5MEBKSzVyIE2gNU4zKM7:TT6= NWnB[lJZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmwPVE2PTlpPkG5NFkyPTV7PD;hQi=>
Shh-Light2 MkXxSpVv[3Srb36gZZN{[Xl? MYm0PEBpenN? MV;Jcohq[mm2aX;uJI9nKFOKSDDpckBud3W|ZTDTbIguVGmpaISyJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCJbHmxJJJmeG:{dHXyJIdmdmViYYPzZZkhcW5icILld4Vv[2Vib3[gV2FINCCLQ{WwJF0hOS5|MUKg{txONg>? NVvHb4w2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm1OFE1QTBpPkG5OVQyPDlyPD;hQi=>
MEF MXfGeY5kfGmxbjDhd5NigQ>? NYTxUYJRUW6qaXLpeIlwdiCxZjDTcY8hcW5ibX;1d4UhWHSlaD3k[YZq[2mnboSgUWVHKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gV4hpNWmwZIXj[YQhT2yrMTD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHluIFnDOVAhRSBzLkWg{txONg>? MmrqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyN{S1OFEoRjJ|MEe0OVQyRC:jPh?=
MEF NX;UV3c1TnWwY4Tpc44h[XO|YYm= NWfYNlF[OzBiaILz MUHJcohq[mm2aX;uJI9nKFOvbzDpckBud3W|ZTDQeINpNWSnZnnjbYVvfCCPRV[gZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCVaHitbY5lfWOnZDDHcIkuemW|cH;ud4l3\SCkZYTh[4Ft[WO2b4Pp[IF{\SCjY4Tpeol1gSCjZoTldkA{OCCqcoOgZpkhSmW2YVfMc{Bie3OjeTygTWM2OCB;IEGuPUDPxE1w M1\UelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEe0OVQyLz5{M{C3OFU1OTxxYU6=
neural precursor cells MmDPRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NXLkbYx[SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDu[ZVz[WxicILlZ5Vze2:{IHPlcIx{KGK7IHPvcI9vgSCob4LtZZRqd25iYYPzZZktKEWFNUCgQUAyOy52NDFOwG0v NYDISpd{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe0NVc3OzFpPkG3OFE4PjNzPD;hQi=>
U87 NYS3d4VzS3m2b4TvfIlkcXS7IHHzd4F6 M1LKeWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHU5PyClZXzsd{Bie3Onc4Pl[EBieyC4aXHibYxqfHliaX6gdJJme2WwY3Wgc4Yh[mW2YTDncJVkfXKxbnnkZZNmNCCLQ{WwJF0hOTVwNTFOwG0v MkW3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMU[5NFQoRjJyMUG2PVA1RC:jPh?=
U87MG MnTIRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M2TpZ|czKGi{cx?= NV;RTYhySW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDVPFdOTyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRUKGG|c3H5MEBKSzVyIE2gNlIvPSEQvF2u MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ{Nk[1O{c,OjJ{Mk[2OVc9N2F-
A549 NFz2SYtCdnSrY3HuZ4VzKGG|c3H5 NV63eXFpSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[nliTWTTJIF{e2G7LDDJR|UxKD1iNEmg{txONg>? NEPic5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEKyNVg4Oid-MUiyNlE5PzJ:L3G+
DU145 MmHmS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NEjvPVk2KHWP NHrDSnY6PiCqcoO= MVPHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDEWVE1PSClZXzsd{BifCB3IIXNJIFnfGW{IEm2JIhzew>? MlvkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh{NEmxNlUoRjF6MkS5NVI2RC:jPh?=
DU145 MVnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M33hOFExKHWP M4LPcFk3KGi{cx?= M1y3WGdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJGRWOTR3IHPlcIx{KGG2IEGwJJVOKGGodHXyJFk3KGi{cx?= MlXxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh{NEmxNlUoRjF6MkS5NVI2RC:jPh?=
HEK293 MYHGeY5kfGmxbjDhd5NigQ>? MU\Jcohq[mm2aX;uJI9nKGKndHGg[4Ft[WO2b4Pp[IF{\SCrbjDISWszQTNiY3XscJM> MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzR7NEe2Okc,OTd2OUS3OlY9N2F-
22Rv NGHvNYpHfW6ldHnvckBie3OjeR?= M4LBUXJm\HWldHnvckBw\iCneIDy[ZN{cW:wIH;mJHBVS0hibWLORUBqdiCqdX3hckAzOlK4IHPlcIx{ NXzhR4dERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe0PVQ4PjZpPkG3OFk1PzZ4PD;hQi=>
PANC1 MmjPSpVv[3Srb36gZZN{[Xl? MXqwMlIhfU1? MWCyOEBpenN? M4j3Z2lvcGmkaYTpc44hd2ZiSHivS2xKOS2vZXTpZZRm\CCSVFPIJI1TVkFiZYjwdoV{e2mxbjDpckBpfW2jbjDQRW5EOSClZXzsd{BifCByLkKgeW0h[W[2ZYKgNlQhcHK|IHL5JHJVNVCFUh?= NIK2SoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MES1NFE4OCd-MkC0OVAyPzB:L3G+
PANC1 MW\GeY5kfGmxbjDhd5NigQ>? MX2wMlQhfU1? NWS0VYR3OjRiaILz NX3yR25GUW6qaXLpeIlwdiCxZjDIbE9IVElzLX3l[IlifGWmIGDUR2ghdVKQQTDlfJBz\XO|aX;uJIlvKGi3bXHuJHBCVkNzIHPlcIx{KGG2IECuOEB2VSCjZoTldkAzPCCqcoOgZpkhWlRvUFPS MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODR3MEG3NEc,OjB2NUCxO|A9N2F-
Shh Light2 Mk\6SpVv[3Srb36gZZN{[Xl? MVe2MlI2KHWP MnvYN|AhcHK| NFvET2tKdmirYnn0bY9vKG:oIF6tdIFtdWm2b4nsZZRm\CCVaHigbY4hdW:3c3WgV4hpKEyrZ3j0NkBk\WyuczDheEA3NjJ3IIXNJIFnfGW{IEOwJIhzeyCkeTDmbZJm\my7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> M3vT[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MUWxO|MyLz5zOUG1NVc{OTxxYU6=
U87MG NXnPbYtGTnWwY4Tpc44h[XO|YYm= NUf1Zo5sOTBidV2= MmnKOEBpenN? NH7PSoRKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJIh2dWGwIGW4O21IKGOnbHzzJIF{e2W|c3XkJIF{KGSxd36gdoVofWyjdHnvckBw\iCJbHmxJIF1KDFyIIXNJIFnfGW{IESgbJJ{KGK7IGLUMXBEWiCjbnHsfZNqew>? NFTRO409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkKyOlY2Pyd-MkKyNlY3PTd:L3G+
HEK293 MnvqSpVv[3Srb36gZZN{[Xl? NEf4fWk2KHWP MlTHNVAhcHK| MX3EbZNxdGGlZX3lcpQhd2ZiQl;ETXB[NWO7Y3zvdIFucW6nIH\yc40hcHWvYX6gV41wKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[XRiNTD1UUBu\WG|dYLl[EBi\nSncjCxNEBpenNiYomgSGFRUSC|dHHpcolv\yCkYYPl[EBndHWxcnXzZ4Vv[2VibXnjdo9{[2:yaXOgZZN{[Xl? NY[zTow6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3N|YxPjNpPkK3O|M3ODZ|PD;hQi=>
HEK293 NHzNcotHfW6ldHnvckBie3OjeR?= MYW1JJVO NV3yV2wzOTBiaILz M{frRWRqe3CuYXPlcYVvfCCxZjDCU2RKWFlvY4njcI9x[W2rbnWg[pJwdSCqdX3hckBUdW9iZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjdDC1JJVOKG2nYYP1doVlKGGodHXyJFExKGi{czDifUBHSUOVIHHuZYx6e2m| MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzd|NkC2N{c,Ojd5M{[wOlM9N2F-
C3H10T1/2 M2XJ[2Z2dmO2aX;uJIF{e2G7 M4G1[lU2NjVidH:gOFUxOCCwTR?= MnGzR49ueGW2aYTpeoUhcW6qaXLpeIlwdiCxZjDTcY8hcW5ibX;1d4UhSzOKMUDUNU8zKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gV2FINWmwZIXj[YQhT2yrMTD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliYYSgOVUvPSC2bzC0OVAxKG6PIHL5JJFRS1JiYX7hcJl{cXN? M4HxXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEe0OVQyLz5{M{C3OFU1OTxxYU6=
U2OS MljhSpVv[3Srb36gZZN{[Xl? MmP1OUB2VQ>? MmrTOkBpenN? MXLBcpRi\2:waYP0JIFkfGm4aYT5JIF1KGOqaX3ldolkKFOvbzC2N|MhdXW2YX70JIV5eHKnc4Pl[EBqdiCXMl;TJINmdGy|IHPv[ZhxemW|c3nu[{Bj\XSjIHHydoV{fGmwMj3HSnAh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBqdnS{YXPlcIx2dGG{IHLleIEh[XK{ZYP0bY4zNUeIUDDh[4dz\WejdHWg[o9zdWG2aX;uJIF1KDVidV2gZYZ1\XJiNjDodpMh[nliY3;u[o9k[WxibXnjdo9{[2:yeR?= NV3idlNLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOlM2OjJpPkKzNFY{PTJ{PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
Snail / E-cadherin / Slug / Vimentin ; 

PubMed: 26859575     


SW1736 and WRO82 cells were incubated in the presence of vehicle (0.5% DMSO) or the indicated concentrations of cyclopamine or GANT61 for 72 hr. The cells were harvested and analyzed for the expression of several genes involved in EMT.

Gli1 / TGF-β1 / CXCR4; 

PubMed: 26137001     


Western blotting demonstrated that Gli1, TGF-β1 and CXCR4 protein expression levels were downregulated in the AGS cells treated with cyclopamine for 24 h.

NF-κB / Cyclin D1 / MMP2 / MMP9; 

PubMed: 23599805     


Whole cell lysates were prepared, and 50 μg proteins were resolved using SDS-PAGE, followed by immunoblotting with the indicated specific antibodies against NF-κB, cyclin D1, MMP2 and MMP9. 

26859575 26137001 23599805
Immunofluorescence
PCNA / β-catenin; 

PubMed: 28747625     


Immunofluorescence images demonstrating the distribution of PCNA or β-catenin in EH cells pre-treated with cyclopamine in presence and absence of estrogen for 24 h. Experiments were repeated at least three times.

Vimentin; 

PubMed: 24553082     


Vimentin protein expression was reduced following treatment with cyclopamine (20 μmol/L; 72 h), detected by immunocytochemistry.

28747625 24553082
In vivo Administration of Cyclopamine at dose of 50 mg/kg/day for 22 days eradicates the HUCCT1 xenografts in mice with no obvious adverse effects. [2] Cyclopamine treatment at dose of 1.2 mg for 7 days induces significant apoptosis of tumor cells and decreases the tumor mass by 50-60% in Panc 05.04- and L3.6sl-derived tumors, respectively, but not in the BxPC3-SMOlow tumors. [3] Administration of Cyclopamine alone profoundly inhibits tumor metastases in xenografts of E3LZ10.7 and L3.6pl, and completely abrogates metastases when in combination of gemcitabine. [4]

Protocol

Kinase Assay:[1]
- Collapse

Hedgehog cell assay:

This assay measures the end stage of the Hh signaling pathway, that is, the transcriptional modulation of Gli, using Luciferase as readout (Gli-Luc assay). Cyclopamine is prepared for assay by serial dilution in DMSO and then added to empty assay plates. TM3Hh12 cells (TM3 cells containing Hh-responsive reporter gene construct pTA-8xGli-Luc) are resuspended in F12 Ham's/DMEM (1:1) containing 5% FBS and 15 mM Hepes pH 7.3, added to assay plates and incubated with Cyclopamine for approximately 30 minutes at 37 °C in 5% CO2. 1 nM Hh-Ag 1.5 is then added to assay plates and incubated at 37 °C in the presence of 5% CO2. After 48 hours, either Bright-Glo or MTS reagent is added to the assay plates and luminescence or absorbance at 492 nm is determined. IC50 value, defined as the inflection point of the logistic curve, is determined by non-linear regression of the Gli-driven luciferase luminescence or absorbance signal from MTS assay vs log10 (concentration) of Cyclopamine using the R statistical software pack
Cell Research:[2]
- Collapse
  • Cell lines: SEG1, OE33, KYAE, KYSE180, SNU1, AGS, SNU16, NCI-N-87, HUCCT1, PANC1, PL5, PL6, BXPC3, HS766T, KYSE150, GBD1, DLD1, and HCT116
  • Concentrations: Dissolved in DMSO, final concentration 3 μM
  • Incubation Time: 4 days
  • Method: Cells are exposed to Cyclopamine in 96-well plates. Cell viability is measured by MTS (soluble tetrazolium salt) assay. Viable cell mass is determined by optical density measurements at 490 nm (OD490) at 2 and 4 days using the CellTiter96 colorimetric assay. Relative growth is calculated as OD (day 4)﹣OD (day 2)/OD (day 2).
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Athymic (nude) mice inoculated subcutaneously with HUCCT1 cells
  • Dosages: 50 mg/kg/day
  • Administration: Subcutaneous injection
    (Only for Reference)

Solubility (25°C)

In vitro DMF 10 mg/mL warmed (24.29 mM)
Ethanol 2 mg/mL warmed (4.85 mM)
DMSO Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 411.62
Formula

C27H41NO2

CAS No. 4449-51-8
Storage powder
in solvent
Synonyms 11-deoxojervine
Smiles CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How to reconstitute the compound for in vivo use in mice?

  • Answer:

    One paper dissolved this drug in DMSO, and diluted in saline: Berman DM, et al. Nature, 2003, 425(6960), 846-851. Alternatively, you can try this vehicle: 10% DMSO+30% PEG 300+5% Tween 80+ddH2O for P.O. When preparing the solution, please dissolve the compound in DMSO clearly first. Then add PEG300 and Tween, after they mixed well, dilute with water.

Hedgehog/Smoothened Signaling Pathway Map

Hedgehog/Smoothened Inhibitors with Unique Features

Related Hedgehog/Smoothened Products

Tags: buy Cyclopamine | Cyclopamine supplier | purchase Cyclopamine | Cyclopamine cost | Cyclopamine manufacturer | order Cyclopamine | Cyclopamine distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID